FNBT
CBST

FineMark National Bank & Trust’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

FineMark National Bank & Trust’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-500
Closed -$50K – 1509
2014
Q4 		$50K Hold
500
– – 0.01% 668
2014
Q3 		$33K Hold
500
– – 0.01% 755
2014
Q2 		$35K Hold
500
– – 0.01% 738
2014
Q1 		$37K Hold
500
– – 0.01% 695
2013
Q4 		$34K Hold
500
– – 0.01% 679
2013
Q3 		$32K Hold
500
– – 0.01% 672
2013
Q2 		$24K Buy
+500
New +$24.6K 0.01% 749

FineMark National Bank & Trust's CBST Position: Q1 2015 in Review

FineMark National Bank & Trust sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2015, closing a stake of 500 shares — an estimated $50K sold.

FineMark National Bank & Trust first reported a position in CBST in Q2 2013 and held it in 7 quarters. The position peaked at $50K in Q4 2014. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.

  • FineMark National Bank & Trust reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • FineMark National Bank & Trust sold 500 CUBIST PHARMACEUTICALS INC shares in Q1 2015, an estimated $50K.
  • FineMark National Bank & Trust first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • FineMark National Bank & Trust's CUBIST PHARMACEUTICALS INC position peaked at $50K in Q4 2014.
  • 0 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2015.

Based on FineMark National Bank & Trust's 13F filing for Q1 2015, filed 13 May 2015.